Imaging Institute/A21, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44120, USA.
Skeletal Radiol. 2010 Aug;39(8):791-8. doi: 10.1007/s00256-009-0822-7. Epub 2009 Nov 20.
To evaluate the radiographic and magnetic resonance (MR) imaging features of primary and secondary malignant fibrous histiocytoma in bone and determine the demographics, prevalence and outcome of patients with this tumor.
A retrospective search of files from two institutions identified 28 patients with malignant fibrous histiocytoma (MFH) of bone. Microscope slides were reviewed to confirm diagnosis and identify any pre-existing lesions. Medical records were reviewed with respect to patients' demographic characteristics and outcomes.
Radiographic features demonstrated an aggressive osteolytic lesion with a permeative pattern of bone destruction. Periosteal reaction was seen in three of 13 lesions. T1-weighted images (T1WIs) demonstrated signal intensity iso- to slightly hyperintense to muscle. T2-weighted images (T2WIs) demonstrated mildly higher signal intensity than that of muscle. The 5-year survival rate was 53%. The tumor arose secondarily in pre-existing lesions in 43% of patients. Metastases occurred in 46% of patients during the course of the disease, with pulmonary and osseous metastases being the most common.
Secondary MFH of bone was slightly less common than primary MFH and had a prognosis similar to that of primary MFH of bone. MR imaging showed variable and somewhat unusual low to intermediate T2 signal characteristics for a radiographically malignant osteolytic lesion.
评估原发性和继发性恶性纤维组织细胞瘤在骨骼中的放射学和磁共振(MR)成像特征,并确定患有这种肿瘤的患者的人口统计学、患病率和结局。
对两家机构的档案进行回顾性检索,共确定了 28 例骨恶性纤维组织细胞瘤(MFH)患者。通过显微镜载玻片复查来确认诊断,并确定任何先前存在的病变。通过回顾病历,分析患者的人口统计学特征和结局。
放射学特征表现为侵袭性溶骨性病变,具有弥漫性骨破坏模式。13 个病灶中有 3 个可见骨膜反应。T1 加权图像(T1WI)显示信号强度与肌肉等信号至轻度高信号。T2 加权图像(T2WI)显示信号强度比肌肉稍高。5 年生存率为 53%。肿瘤在 43%的患者中继发于先前存在的病变。在疾病过程中,46%的患者发生转移,肺和骨转移最为常见。
继发性骨恶性纤维组织细胞瘤比原发性骨恶性纤维组织细胞瘤略少见,其预后与原发性骨恶性纤维组织细胞瘤相似。MR 成像显示,在放射学上为恶性溶骨性病变的情况下,T2 信号的低到中等范围存在变化,且有些不寻常。